Found 1 articles for: "IL-4"

Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade

October 2023 | Volume 22 | Issue 10 | Editorials | 1007 | Copyright © October 2023

In 2017, dupilumab became the first FDA approved systemic therapy for atopic dermatitis. Since its approval, extensive clinical experience and continued research have revealed a number of unexpected e...
Read More